-
OQR eCQMs - Outpatient Quality Reporting
-
Resolution: Done
-
Moderate
-
None
-
None
The Thrombolytic Medication value set includes tenecteplase and reteplase, but there is not a type equivalent to these medications in the Adverse reaction to Thrombolytics value set. Is the intent that tenecteplase and reteplase should align with "Alteplase" in the Adverse reaction to Thombolytics value set?
Adverse reaction to thrombolytics OID: 2.16.840.1.113762.1.4.1170.6 includes the following codes:
293571007 Streptokinase adverse reaction (disorder) SNOMEDCT 2021-09 2.16.840.1.113883.6.96
293572000 Urokinase adverse reaction (disorder) SNOMEDCT 2021-09 2.16.840.1.113883.6.96
293573005 Alteplase adverse reaction (disorder) SNOMEDCT 2021-09 2.16.840.1.113883.6.96
293574004 Anistreplase adverse reaction (disorder) SNOMEDCT 2021-09 2.16.840.1.113883.6.96
Thrombolytic medications OID: 2.16.840.1.113762.1.4.1170.4 includes the following codes:
10106 streptokinase RXNORM 2022-01 2.16.840.1.113883.6.88
11055 urokinase RXNORM 2022-01 2.16.840.1.113883.6.88
259280 tenecteplase RXNORM 2022-01 2.16.840.1.113883.6.88
40028 anistreplase RXNORM 2022-01 2.16.840.1.113883.6.88
76895 reteplase RXNORM 2022-01 2.16.840.1.113883.6.88
8410 alteplase RXNORM 2022-01 2.16.840.1.113883.6.88
UNION "Adverse Effect to Thrombolytic Medications Before End of ED Encounter"
"ED Encounter with STEMI Diagnosis" EDwSTEMI
WITH ["Adverse Event": "Thrombolytic medications"] ThrombolyticAdverseEvent
SUCH THAT ThrombolyticAdverseEvent.type in "Adverse reaction to thrombolytics"
AND ThrombolyticAdverseEvent.relevantDatetime before
end of EDwSTEMI.relevantPeriod